| Project/Area Number |
20590899
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | The University of Tokushima |
|---|
Principal Investigator |
AZUMA Masahiko The University of Tokushima, 病院, 講師 (80325282)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
OGAWA Hirohisa 徳島大学, 大学院・ヘルスバイオサイエンス研究部, 助教 (50403754)
西岡 安彦 徳島大学, 大学院・ヘルスバイオサイエンス研究部, 准教授 (70274199)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
NISHIOKA Yasuhiko 徳島大学, 大学院・ヘルスバイオサイエンス研究部, 准教授 (70274199)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 閉塞性肺疾患 / アレルギー / 喘息 / ぜんそく |
|---|
| Research Abstract |
Chronic allergic airway inflammation induced refractory asthma. Especially transcription factor NF-kappa B plays central roll in these inflammations. We analyze inhibitory effect of IMD-0354, which specific I kappa-beta-kinase inhibitor, on bronchial hyperresponsiveness, airway inflammation and remodeling in airway. IMD-0354 reduce airway hyperresponsiveness, the production of Th2 cytokines, goblet cell hyperplasia, and bronchial smooth muscle hypertrophy. IMD-0354 had no adverse effects in this study. These results indicate the possibility of anti-asthmatic effects of this drug.
|
